A GLP-1R agonist/GIPR antagonist peptide is theoretically possible but few full-length GIP-like antagonists were reported, 60 therefore it requires an array of attempts, at least an alanine-scan experiment of GIP with measuring of affinity
Inflammation benefits are also inconsistent when dosing is not done with regard to the half-life, but long term inflammation effects and inconsistency is not known
Hyperglycemia is less dangerous than hypoglycemia
Building a Scalable GLP-1 Virtual Clinic with Specode: Fast, Secure, and Customizable Bringing a GLP-1 virtual clinic to market is no small feat
However, he's not ever changing the name that now feels more ironic
Furthermore, investigating the potential of these agents in other organ systems affected by sepsis could broaden the scope of their therapeutic applications